Ashley Gallagher

FDA approves Leqembi's subcutaneous formulation, enhancing accessibility for Alzheimer treatment and paving the way for future combination therapies.

Pharmacists navigate complex immunization challenges and address parental concerns and misinformation while advocating for streamlined vaccine access and adherence to evolving guidelines.

Laura Knockel, PharmD, BCACP, emphasize the importance of evidence-based recommendations and reliable resources for parents.

Childhood immunization guidance in the US faces confusion as the AAP and CDC diverge on COVID-19 vaccine recommendations, impacting parents and providers.

Confusion arises as health organizations diverge on COVID-19 vaccine recommendations for children, highlighting the need for clear guidance and support.

Liraglutide is the first glucagon-like peptide-1 to have a generic equivalent for both type 2 diabetes and obesity indications.

The approved vaccines include Novavax’s Nuvaxovid and Moderna’s Spikevax and mNexspike.

The approval covers Pfizer and BioNTech’s LP.8.1-adapted monovalent COVID-19 vaccine, which is also indicated for patients aged 5 to 64 with at least 1 underlying condition.

However, caution with empagliflozin use should be applied for patients previously taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.

Certified diabetes care and education specialists and clinical pharmacists are essential members of diabetes care teams.

Investigators emphasize the importance of proper education regarding diabetes and continuous glucose monitors.

A range of evidence-based strategies for managing menstrual pain, such as heat therapy and gentle exercise, can help improve menstrual pain.

Investigators find this association primarily affects female patients when compared with male patients.

The FDA removes the prior requirement for a patient who is already diagnosed with a cardiovascular disease.

Palmer addresses the limitations of alternative methods such as acetaminophen, herbal supplements, and cannabis products, urging patients to consult health care professionals.

Michelle Palmer, PharmD, FASCP, also emphasizes the importance of heat therapy, gentle exercise, adequate sleep, and relaxation techniques as management techniques.

The Signos Glucose Monitoring System uses body signals that help to improve sleep, manage weight, and decrease the risk of chronic disease.

Discover effective over-the-counter solutions for menstrual cramps, including NSAIDs and alternative therapies, to alleviate pain and discomfort.

Chronic pain affects many older adults, highlighting the need for safe acetaminophen use and effective pain management strategies.

Currently, systemic estrogen replacement therapy is contraindicated for women who have a history of ischemic stroke due to the risk of stroke recurrence.

New clinical trial results reveal upadacitinib's effectiveness in achieving significant hair regrowth for patients with severe alopecia areata.

Simultaneous vaccination with IIV4 and PPSV23 proves safe and effective for patients with chronic diseases, matching results of healthy individuals.

Recent studies reveal that while diabetes technology use rises, glycemic control in type 1 diabetes patients remains low, highlighting significant disparities.

Pharmacies face significant challenges in filling buprenorphine prescriptions for telemedicine patients, impacting opioid use disorder treatment access and patient satisfaction.

DTC pharmacies offer significant savings on total medication costs for neurological drugs, but out-of-pocket expenses remain high for insured patients.

Investigators found that Opill increased access for patients who were uninsured, identified as Black or Latina, had lower education, and lived in the Southern United States.

Pharmacists leverage socioeconomic insights to combat health disparities, enhancing access to medications and public health services in underserved communities.

Cyclobenzaprine HCl sublingual tablets (Tonmya) are the first new FDA-approved therapy for fibromyalgia in over 15 years.

FDA approves Wegovy for treating metabolic dysfunction–associated steatohepatitis, marking a breakthrough in liver health management and patient care.

As pharmacies face mounting challenges from changing reimbursement models, understanding and managing revenue cycles has never been more critical.